Advertisement

Topics

Immunomic Therapeutics CEO to Present at Precision Medicine World Conference (PMWC): Emerging Therapeutics Showcase

06:00 EDT 24 Sep 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Presentation to Highlight UNITE Potential Capabilities in Immuno-Oncology Tomorrow, Dr. William Hearl, Ph.D., Chief Executive Officer (CEO) of Immunomic Therapeutics, Inc. will present at the Precision Medicine World ...

Other Sources for this Article

Immunomic Therapeutics
Sia Anagnostou, 717-327-1822

NEXT ARTICLE

More From BioPortfolio on "Immunomic Therapeutics CEO to Present at Precision Medicine World Conference (PMWC): Emerging Therapeutics Showcase"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under twenty, but the family of molecules have very similar a...